만성 B형 간염 환자에서 Pegylated 인터페론 알파2a 치료 중 발생한 원형 탈모Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B
- Other Titles
- Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B
- Authors
- 김예슬; 이상훈; 이강모; 배유인; 박영립
- Issue Date
- 2014
- Publisher
- 대한피부과학회
- Keywords
- Alopecia areata; Pegylated interferon
- Citation
- 대한피부과학회지, v.52, no.1, pp.40 - 43
- Journal Title
- 대한피부과학회지
- Volume
- 52
- Number
- 1
- Start Page
- 40
- End Page
- 43
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13007
- ISSN
- 0494-4739
- Abstract
- Recent studies recommend pegylated interferon alpha2a as the first choice treatment for chronic hepatitis B,especially when the patient is negative for HBeAg. Pegylated interferon alpha is known to show variable side effectsincluding skin symptoms, with alopecia as the most common dermatologic side effect experienced for 10% up to36%. pcc) Most alopecia cases related to pegylated interferon alpha were presented with telogen effluvium pattern,but alopecia areata cases are reported rarely. In this case, typically localized alopecia areata was presented withpegylated interferon alpha2a treatment in hepatitis B patient, and the course of alopecia areata seemed to be relatedwith administration and discontinuation of pegylated interferon alpha2a.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Dermatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.